Literature DB >> 15301677

Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect.

S M Arend1, E Cerdá de Palou, P de Haas, R Janssen, M A Hoeve, E M Verhard, T H M Ottenhoff, D van Soolingen, J T van Dissel.   

Abstract

The clinical and epidemiological characteristics of 17 patients diagnosed with Mycobacterium kansasii pneumonia within a limited geographical region over a period of 10 years are described. An in-depth evaluation of the innate and adaptive immune systems was performed for five available patients. A comparison was made of the genetic fingerprint patterns of the isolates obtained by restriction fragment length polymorphism (RFLP) analysis, with the major polymorphic tandem repeat (MPTR) as a probe. Predisposing factors consisted of smoking, airway abnormalities, substance abuse, diabetes or poor general condition, but in two patients no risk factor was identified. In the five patients tested, no abnormalities or deficiencies were detected in the innate or adaptive type-1 immunity. All M. kansasii isolates had identical MPTR RFLP patterns, although no epidemiological connection could be established, and these were identical to those of clinical isolates from Australian patients. These data do not support the theory that defects in the innate or adaptive type-1 immunity have a role in the pathogenesis of invasive M. kansasii infections. The identical fingerprint patterns of the isolates suggested the existence of a virulent strain of M. kansasii.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301677     DOI: 10.1111/j.1469-0691.2004.00898.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level.

Authors:  H Martin Vordermeier; Jemma Brown; Paul J Cockle; Willeke P J Franken; Jan Wouter Drijfhout; Sandra M Arend; Tom H M Ottenhoff; Keith Jahans; R Glyn Hewinson
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

3.  Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.

Authors:  Suhail Ahmad; Eiman Mokaddas
Journal:  Med Princ Pract       Date:  2019-02-14       Impact factor: 1.927

4.  Recurrent mycobacterial infections in a patient with IL-12 deficiency.

Authors:  Matthew Buckland; Roshanara Ali; Graham Bothamley; David Lammas; Rainer Doffinger; Hilary Longhurst
Journal:  BMJ Case Rep       Date:  2009-12-01

5.  Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii.

Authors:  W R Waters; M V Palmer; T C Thacker; J B Payeur; N B Harris; F C Minion; R Greenwald; J Esfandiari; P Andersen; J McNair; J M Pollock; K P Lyashchenko
Journal:  Clin Vaccine Immunol       Date:  2006-06

6.  Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network.

Authors:  Vincent Thomas; Katia Herrera-Rimann; Dominique S Blanc; Gilbert Greub
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Immune responses in cattle inoculated with Mycobacterium bovis, Mycobacterium tuberculosis, or Mycobacterium kansasii.

Authors:  W R Waters; A O Whelan; K P Lyashchenko; R Greenwald; M V Palmer; B N Harris; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

8.  Lithium inhibits growth of intracellular Mycobacterium kansasii through enhancement of macrophage apoptosis.

Authors:  Hosung Sohn; Kwangwook Kim; Kil-Soo Lee; Han-Gyu Choi; Kang-In Lee; A-Rum Shin; Jong-Seok Kim; Sung Jae Shin; Chang-Hwa Song; Jeong-Kyu Park; Hwa-Jung Kim
Journal:  J Microbiol       Date:  2014-02-17       Impact factor: 3.422

9.  Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.

Authors:  Chang-Chieh Chen; Sheng-Hui Tsai; Chia-Chen Lu; Shiau-Ting Hu; Ting-Shu Wu; Tsung-Teng Huang; Najwane Saïd-Sadier; David M Ojcius; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

10.  The R156H variation in IL-12Rβ1 is not a mutation.

Authors:  Esther van de Vosse; Jaap T van Dissel; Loredana Palamaro; Giuliana Giardino; Francesca Santamaria; Rosa Romano; Anna Fusco; Silvia Montella; Mariacarolina Salerno; Matilde Valeria Ursini; Claudio Pignata
Journal:  Ital J Pediatr       Date:  2013-02-14       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.